Messenger RNA vaccines pose no risk to pregnant women and babies, says the European Medicines Agency.
Studies with pregnant women have revealed that the Pfizer and Moderna COVID-19 vaccines pose no risk to mothers or babies.
Da RFI - According to a statement issued by the European regulator, research conducted with 65,000 women showed "increasingly strong evidence" that injections of the Pfizer and Moderna vaccines do not cause complications during pregnancy. The agency also indicates that COVID-19 immunization provides important protection against hospitalizations and deaths, particularly in late pregnancies.
"The analyses did not identify any signs of risk of complications during pregnancy, miscarriages, premature births, or consequences for babies born after pregnant women were vaccinated with messenger RNA vaccines," the document reiterates. The agency also notes that "research shows that the advantages of vaccines during pregnancy outweigh any possible risks to pregnant women and fetuses."
The European regulator emphasizes that pregnancy itself is associated with a higher risk of a severe form of Covid-19 in the second and third trimesters of pregnancy. This shows "that expectant mothers should get vaccinated," the document concludes.
The European Medicines Agency also indicated that it will begin examining the effects on mothers and babies of other vaccines used so far.
Risks of cardiovascular problems
Another study, released this Tuesday by the French Medicines Agency, indicated that messenger RNA vaccines also do not increase the risk of serious cardiovascular problems in people under 75 years of age. The research was conducted with all people aged 18 to 74, vaccinated or not, who were admitted to French hospitals between December 27, 2020, and July 20, 2021, for problems such as acute myocardial infarction, ischemic or hemorrhagic stroke, and pulmonary embolism.
The results confirm "the safety of messenger RNA vaccines" in the three weeks following the first or second dose of the Pfizer and Moderna vaccines. However, the French Medicines Agency indicates that the AstraZeneca and Johnson & Johnson vaccines appear to be "associated with a slight increased risk of myocardial infarction and pulmonary embolism in adults" two weeks after injection.
The studies corroborate other international research conducted on the risks of side effects caused by anti-COVID vaccines. The French agency also points out that COVID-19 itself is strongly associated with a risk of cardiovascular complications.